三阴乳腺癌组织中VEGF、KAI-1、c-kit的表达及临床病理意义  被引量:2

Expression and clinical pathological significance of VEGF,KAI-1,c-kit in triple-negative breast cancer

在线阅读下载全文

作  者:徐雪瑶[1] 赵峰[1] 张银华[1] 梁莉萍[1] 

机构地区:[1]新疆医科大学附属肿瘤医院病理科,新疆乌鲁木齐830011

出  处:《新疆医科大学学报》2011年第5期504-508,共5页Journal of Xinjiang Medical University

摘  要:目的探讨VEGF(vascular endothelial growth factor)、KAI-1(Kang Ai1,抗癌1号,CD82)、c-kit(CD117)在三阴乳腺癌组织中的表达及临床病理意义。方法应用免疫组织化学PV-9000法检测85例三阴乳腺癌(triple-negative breast cancer,TNBC)组织中VEGF、KAI-1、c-kit的表达。结果 (1)TNBC中VEGF阳性表达率为76.47%(65/85),VEGF表达在不同肿瘤大小各组间差异有统计学意义(P<0.05)。(2)TNBC中KAI-1阳性表达率为42.35%(36/85),KAI-1的表达在不同肿瘤大小、不同淋巴结转移情况、复发与否各组间差异有统计学意义(P<0.05)。(3)TNBC中c-kit阳性表达率为44.70%(38/85),c-kit的表达在不同肿瘤大小,不同临床分期,不同淋巴结转移情况各组间差异有统计学意义(P<0.05)。结论 VEGF阳性表达、KAI-1阴性表达、c-kit阴性表达均对三阴乳腺癌生长有一定意义,KAI-1和c-kit参与三阴乳腺癌转移,可以成为预测转移的参考指标。Objective To explore the expression and clinical pathological significance of VEGF,KAI-1,c-kit in triple-negative breast cancer.Methods PV-9000 immunohistochemistry technique was applied to detect the expression of VEGF,KAI-1,c-kit in 85 triple-negative breast cancer cases.Results (1) The positive rate of VEGF was 76.47%(65/85) in TNBC.The expression of VEGF was associated with tumor size(P0.05).(2) The positive rate of KAI-1 in TNBC was 42.35%(36/85).The expression of KAI-1 was associated with size,metastasis of lymph nodes and recurrence(P0.05).(3) The positive rate of c-kit in TNBC was 44.70%(38/85).The expression of c-kit was associated with size,metastasis of lymph nodes and clinical stage(P0.05).Conclusion The positive expression of VEGF,the negative expression of KAI-1,the negative expression of c-kit may contribute to the growth of triple-negative breast cancer.KAI-1 and c-kit may play important roles in triple-negative breast cancer metastasis and might serve as a marker to predict metastasis.

关 键 词:VEGF KAI-1 C-KIT 三阴乳腺癌 免疫组织化学 

分 类 号:R737.9[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象